Literature DB >> 16575552

Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.

Jordi Riba1, Sergio Romero, Eva Grasa, Esther Mena, Ignasi Carrió, Manel J Barbanoj.   

Abstract

RATIONALE: Ayahuasca is a South American psychoactive plant tea which contains the serotonergic psychedelic N,N-dimethyltryptamine (DMT) and monoamine-oxidase inhibitors that render DMT orally active. Previous investigations with ayahuasca have highlighted a psychotropic effect profile characterized by enhanced introspective attention, with individuals reporting altered somatic perceptions and intense emotional modifications, frequently accompanied by visual imagery. Despite recent advances in the study of ayahuasca pharmacology, the neural correlates of acute ayahuasca intoxication remain largely unknown.
OBJECTIVES: To investigate the effects of ayahuasca administration on regional cerebral blood flow.
METHODS: Fifteen male volunteers with prior experience in the use of psychedelics received a single oral dose of encapsulated freeze-dried ayahuasca equivalent to 1.0 mg DMT/kg body weight and a placebo in a randomized double-blind clinical trial. Regional cerebral blood flow was measured 100-110 min after drug administration by means of single photon emission tomography (SPECT).
RESULTS: Ayahuasca administration led to significant activation of frontal and paralimbic brain regions. Increased blood perfusion was observed bilaterally in the anterior insula, with greater intensity in the right hemisphere, and in the anterior cingulate/frontomedial cortex of the right hemisphere, areas previously implicated in somatic awareness, subjective feeling states, and emotional arousal. Additional increases were observed in the left amygdala/parahippocampal gyrus, a structure also involved in emotional arousal.
CONCLUSIONS: The present results suggest that ayahuasca interacts with neural systems that are central to interoception and emotional processing and point to a modulatory role of serotonergic neurotransmission in these processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16575552     DOI: 10.1007/s00213-006-0358-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers.

Authors:  J Riba; A Rodríguez-Fornells; G Urbano; A Morte; R Antonijoan; M Montero; J C Callaway; M J Barbanoj
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

Review 2.  Primate anterior cingulate cortex: where motor control, drive and cognition interface.

Authors:  T Paus
Journal:  Nat Rev Neurosci       Date:  2001-06       Impact factor: 34.870

3.  Subcortical and cortical brain activity during the feeling of self-generated emotions.

Authors:  A R Damasio; T J Grabowski; A Bechara; H Damasio; L L Ponto; J Parvizi; R D Hichwa
Journal:  Nat Neurosci       Date:  2000-10       Impact factor: 24.884

Review 4.  Nosing in on the emotional brain.

Authors:  Stephan Hamann
Journal:  Nat Neurosci       Date:  2003-02       Impact factor: 24.884

5.  Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.

Authors:  C S Grob; D J McKenna; J C Callaway; G S Brito; E S Neves; G Oberlaender; O L Saide; E Labigalini; C Tacla; C T Miranda; R J Strassman; K B Boone
Journal:  J Nerv Ment Dis       Date:  1996-02       Impact factor: 2.254

6.  Pharmacokinetics of Hoasca alkaloids in healthy humans.

Authors:  J C Callaway; D J McKenna; C S Grob; G S Brito; L P Raymon; R E Poland; E N Andrade; E O Andrade; D C Mash
Journal:  J Ethnopharmacol       Date:  1999-06       Impact factor: 4.360

7.  Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Authors:  R J Strassman; C R Qualls; E H Uhlenhuth; R Kellner
Journal:  Arch Gen Psychiatry       Date:  1994-02

8.  Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects.

Authors:  R J Strassman; C R Qualls
Journal:  Arch Gen Psychiatry       Date:  1994-02

9.  Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research.

Authors:  L Hermle; M Fünfgeld; G Oepen; H Botsch; D Borchardt; E Gouzoulis; R A Fehrenbach; M Spitzer
Journal:  Biol Psychiatry       Date:  1992-12-01       Impact factor: 13.382

10.  Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI).

Authors:  X Lamas; M Farré; M Llorente; J Camí
Journal:  Drug Alcohol Depend       Date:  1994-06       Impact factor: 4.492

View more
  51 in total

Review 1.  On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis.

Authors:  Dionysios Grammenos; Steven A Barker
Journal:  J Neural Transm (Vienna)       Date:  2014-11-02       Impact factor: 3.575

Review 2.  [Neurotheology: neurobiological models of religious experience].

Authors:  T Passie; J Warncke; T Peschel; U Ott
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

3.  Impulsivity and executive functions in polysubstance-using rave attenders.

Authors:  Antonio Verdejo-García; María Del Mar Sánchez-Fernández; Luisa María Alonso-Maroto; Fermín Fernández-Calderón; Jose C Perales; Oscar Lozano; Miguel Pérez-García
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

4.  Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users.

Authors:  José Carlos Bouso; Josep Maria Fábregas; Rosa Maria Antonijoan; Antoni Rodríguez-Fornells; Jordi Riba
Journal:  Psychopharmacology (Berl)       Date:  2013-06-21       Impact factor: 4.530

Review 5.  Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

6.  Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion.

Authors:  Draulio B de Araujo; Sidarta Ribeiro; Guillermo A Cecchi; Fabiana M Carvalho; Tiago A Sanchez; Joel P Pinto; Bruno S de Martinis; Jose A Crippa; Jaime E C Hallak; Antonio C Santos
Journal:  Hum Brain Mapp       Date:  2011-09-16       Impact factor: 5.038

7.  Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

Authors:  Benjamin J Malcolm; Kelly C Lee
Journal:  Ment Health Clin       Date:  2018-03-23

Review 8.  The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

Authors:  Robin L Carhart-Harris; Guy M Goodwin
Journal:  Neuropsychopharmacology       Date:  2017-04-26       Impact factor: 7.853

9.  Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.

Authors:  Joaquim Soler; Matilde Elices; Alba Franquesa; Steven Barker; Pablo Friedlander; Amanda Feilding; Juan C Pascual; Jordi Riba
Journal:  Psychopharmacology (Berl)       Date:  2015-11-27       Impact factor: 4.530

10.  Neuroanthropology: evolution and emotional embodiment.

Authors:  Benjamin C Campbell; Justin R Garcia
Journal:  Front Evol Neurosci       Date:  2009-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.